ACT Brief: Real-World Data Across Therapeutic Areas, AI-Driven Case Intake, and COVID-19 Vaccine Trial Enrollment Challenges

In today's ACT Brief, we examine how real-world data is being applied across oncology, ophthalmology, and other therapeutic areas to optimize trial design, how AI is reshaping clinical case intake workflows, and enrollment barriers that led Pfizer and BioNTech to halt a COVID-19 vaccine trial.